Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 14, 2004. The report primarily details changes in directors' interests in the company's ordinary shares and announces a share repurchase transaction executed in accordance with shareholder authority granted at the Annual General Meeting on May 17, 2004.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial data points disclosed relate to the share repurchase and employee plan movements:
- Share Repurchase Price: 1,145.05 pence per share.
- US Retirement Plan ADR Movement: Average price of $42.51.
- Treasury Shares Held: 20,499,000 shares (post-repurchase).
- Shares in Issue: 5,913,080,751 shares (excluding Treasury shares).
Material Changes
The filing reports the following material changes regarding equity and director interests:
- Share Repurchase: On June 11, 2004, the company purchased 850,000 ordinary shares for treasury.
- Employee Trust Transfers: The GSK Trust transferred a total of 21,337 ordinary shares to participants in the SmithKline Beecham Employee Share Option Plan 1991 across three transactions on May 21, June 9, and June 10, 2004.
- US Retirement Plan Adjustment: The number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan decreased from 18,953,031 to 18,920,025 on June 10, 2004.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a procedural disclosure regarding corporate actions and director shareholdings.
Key Facts for Investor Verification
- Verify the total cost of the 850,000 share repurchase (850,000 shares x 1,145.05 pence).
- Confirm the updated total number of shares in issue and treasury holdings as of June 11, 2004.
- Note that directors Dr. J-P Garnier, Dr. T Yamada, and Mr. J D Coombe hold indirect interests in the GSK Trust shares.
- Observe that directors Dr. J-P Garnier and Dr. T Yamada hold potential interests in the US Retirement Savings Plan ADRs.